Mitsubishi UFJ Morgan Stanley Securities’s Biogen BIIB Stock Holding History

Mitsubishi UFJ Morgan Stanley Securities’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$200K	Sell	590 -80	-12%	-$25.9K	0.41%	10
2014 Q3	$222K	Buy	670 +60	+10%	+$19.8K	0.63%	12
2014 Q2	$192K	Buy	610 +100	+20%	+$30.1K	0.56%	13
2014 Q1	$156K	Sell	510 -110	-18%	-$34.9K	0.42%	13
2013 Q4	$173K	Hold	620	–	–	0.29%	15
2013 Q3	$149K	Buy	620 +150	+32%	+$33.6K	0.24%	14
2013 Q2	$101K	Buy	+470	New	+$100K	0.34%	26

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Mitsubishi UFJ Morgan Stanley Securities's BIIB Position: Q4 2014 in Review

Mitsubishi UFJ Morgan Stanley Securities reduced its Biogen (BIIB) stake by 12% in Q4 2014, selling an estimated $25.9K and leaving 590 shares worth $200K. The position accounts for 0.41% of the portfolio, ranked #10.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in BIIB in Q2 2013 and has held it in 7 quarters since. The position peaked at $222K in Q3 2014. 884 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

Mitsubishi UFJ Morgan Stanley Securities held 590 shares of Biogen worth $200K as of Q4 2014.
Mitsubishi UFJ Morgan Stanley Securities sold 80 Biogen shares in Q4 2014, an estimated $25.9K.
Biogen made up 0.41% of Mitsubishi UFJ Morgan Stanley Securities's portfolio in Q4 2014, its #10 holding.
Mitsubishi UFJ Morgan Stanley Securities first reported a position in Biogen in Q2 2013 and has held it in 7 quarters since.
Mitsubishi UFJ Morgan Stanley Securities's Biogen position peaked at $222K in Q3 2014.
884 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q4 2014, filed 17 Feb 2015.